Pablo Sigal
07/03/2021 10:20
Clarín.com
Society
Updated 07/03/2021 10:20
The
"learning over time"
referred to by the Chief of Staff, Santiago Cafiero, to explain why the Argentine Government decided to modify the DNU just
8 months later,
the law that prevented it from buying Pfizer vaccines, cost many deaths to the Argentina.
It is known: the more vaccines are given, the
fewer lives are lost
.
The mathematical estimate indicates that in the country there were
about 11 thousand more deaths
from coronavirus than would have occurred, between the beginning of January and the end of June, if the contract with the US laboratory was signed, as originally stipulated, in December 2020. .
The calculation gives, exactly,
11,227 extra deaths
.
They are approximately 12 percent of the total number of Covid deaths in the country: a little more than one in 10 deaths could have been avoided if Argentina had had that extra amount of vaccines.
In this case, they were the doses offered by the laboratory that carried out its
largest phase 3 trial
at the Central Military Hospital, and the opportunity to have a significant stock was opened due to that privilege.
Pfizer's vaccine, after the successful test in Argentina, was the first to be approved by ANMAT.
The calculation arises from what, it is estimated, would have been to date the amount of vaccines that the country would have received if
a law
had been duly
enacted that would
meet the conditions required by the laboratory in the context of the pandemic.
When everything could be different.
The President with the CEO of Pfizer Argentina, Nicolás Vaquer, and the infectologist Fernando Polack, on July 10, 2020. Photo: Presidency.
Of the total of
13 million doses
that Pfizer offered the country last year before the negotiations bogged down, it is likely that by this time of year
4.9 million would
have arrived
.
While Argentina
could not advance
their contract, Chile, Uruguay, Peru, Brazil, Ecuador, Colombia and Paraguay achieved theirs.
This number of potential vaccines arrived comes from what happened with the deliveries in Chile.
That country contracted 10 million vaccines, received the first batch on December 24, 2020 and in June there were
3.8 million doses landed in its territory
.
Following that proportion, the account would have reported almost 5 million doses to Argentina in the same period.
To date, the country has inoculated a total of 21,643,972 doses, since December 30, and during the first semester it had
50,929 deaths
(there were 43,375 from March to December 2020). If Pfizer's 4.9 million had been added to that stock of doses, the total number of vaccines injected into Argentines would have been
26,543,972
at this
point
. The total of deaths would then have been much lower: between January and June, 39,702.
According to the parameters used by the Ministry of Health itself to calculate how much the number of infections and deaths was reduced from vaccination, it is possible to say that instead of
2,835,540 infections
registered between January 1 and June 30 With the Pfizer vaccines added to the other existing ones, the cases would have dropped to
2,211,776
. That is,
623,764 less
.
Taking into account the fatality rate from Covid for the first half of this year,
1.8 percent
, the number of deaths that would not have taken place out of that total number of cases stands at
11,227
.
Both this figure and the difference in cases that had been registered take into account the proportion of those
vaccinated with one and two doses
in the time period analyzed.
The Legal and Technical Secretary, Vilma Ibarra, yesterday announcing the DNU that from now on the vaccine law changes.
A similar calculation had been made on June 8 by Minister Carla Vizzotti, stating in an official statement: “When one analyzes what would have happened in week 16 to 20 and what actually happened, estimates indicate that
5,500 were avoided deaths
during that period in Argentina ”.
In other words, the minister's projection evaluated five weeks in May.
Using the same criteria, it is now possible to determine how many deaths
have not been prevented
in the 27 weeks that the year has taken, due to the fact that it was not possible to
advance on time
with the Pfizer contract.
Unfortunately, that lost time cannot be made up. The apparent nonsense lies in the fact that it seems to have gone all
the way
back to the point of origin: the Government needed 8 months to find the solution to replace sovereign assets as collateral against possible lawsuits for the creation of a
reparation fund
; and he had no choice, finally, but to eliminate the concept of
"negligence"
from the vaccine law.
The new possibility of buying vaccines from Pfizer - or of receiving a donation from the United States - will now allow not only to add more doses and inoculate a greater number of people with their complete scheme, but that population will probably be made up of
children under 12 years of age. 17 years
, starting with those who suffer from risky pathologies.
Until now, this age group did not have a response in the country and there was a very strong claim from families, although in China the Sinopharm vaccine was approved for children from 3 to 17 years old, as was the Sinovac vaccine.
The latter's trial - not available in Argentina - has already been published in The Lancet magazine.
Now Sinopharm is expected to do the same.
In any case, it also remains for the ANMAT to analyze the
effectiveness and safety
of these vaccines for use by minors.
An advantage in the case of Pfizer is that it has already been authorized by the US FDA for the health target in question.
In fact,
Uruguay and Chile
- which have this vaccine named Comirnaty - have already taken the lead in the region and began vaccinating children under 18 years of age.
$
Look also
They identify the missing variable to determine when the body is protected against Covid
Second dose of Sputnik V: the decision that leaves the Government more exposed to the deficit